S

Shanghai MicroPort EP Medtech Co Ltd
SSE:688351

Watchlist Manager
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Watchlist
Price: 20.07 CNY -6.3% Market Closed
Market Cap: 9.4B CNY
Have any thoughts about
Shanghai MicroPort EP Medtech Co Ltd?
Write Note

Shanghai MicroPort EP Medtech Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai MicroPort EP Medtech Co Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Gross Profit
ÂĄ208.5m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Gross Profit
ÂĄ1.2B
CAGR 3-Years
51%
CAGR 5-Years
48%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Gross Profit
ÂĄ3.6B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Gross Profit
ÂĄ24.2B
CAGR 3-Years
18%
CAGR 5-Years
20%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Gross Profit
ÂĄ1.9B
CAGR 3-Years
0%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Gross Profit
ÂĄ5.5B
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicroPort EP Medtech Co Ltd
Glance View

Market Cap
9.4B CNY
Industry
Health Care

Shanghai MicroPort EP MedTech Co., Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 485 full-time employees. The company went IPO on 2022-08-31. The firm is focused on the fields of electrophysiology intervention treatment and ablation treatment, and it is committed to providing integrated diagnosis and ablation treatment solution with precision intervention navigation at its core. The Company’s main products are heart electrophysiology equipment and related supplies. The firm distributes products both in the domestic market and to overseas markets, including France, Italy, and Spain, among others.

Intrinsic Value
6.42 CNY
Overvaluation 68%
Intrinsic Value
Price
S

See Also

What is Shanghai MicroPort EP Medtech Co Ltd's Gross Profit?
Gross Profit
208.5m CNY

Based on the financial report for Dec 31, 2023, Shanghai MicroPort EP Medtech Co Ltd's Gross Profit amounts to 208.5m CNY.

What is Shanghai MicroPort EP Medtech Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 3Y
27%

Over the last year, the Gross Profit growth was 16%. The average annual Gross Profit growth rates for Shanghai MicroPort EP Medtech Co Ltd have been 27% over the past three years .

Back to Top